|
NANOPARTICLES and NANOTECHNOLOGIES IN MEDICINE 2013
19-20-21 June 2013 Milan Italy
Venue: Zambon conference center – Via Lillo del Duca, 10 - Bresso, Milan Italy
We warmly invite you to be a part of the NANOPARTICLES and NANOTECHNOLOGIES in MEDICINE 2013
International conference devoted to Medical application (design, toxicology, use in diagnosis/ therapy)
of Nanotechnologies.
The conference is organised as part of the final meeting of the NAD Project which is aiming to develop
nanoparticles for Alzheimer's diagnosis and therapy.
The registration is free of charge, please registry at the following link: http://npmed13.eu/online_registration.
Call for oral communications and posters open at the following link: http://npmed13.eu/call_for_abstract
Deadline oral communication submission April 30th 2013
Deadline for registration and poster submission May 15th 2013
_________________________________________________________________________________________________________________________________________
The NAD (Nanoparticles for therapy and diagnosis of Alzheimer's disease) Project is aiming to
develop nanoparticles for Alzheimer's diagnosis and therapy.
Recent statistics estimate that 24.3 million people have dementia today, with 4.6 million new cases of dementia
every year (one new case every 7 seconds). In the EU, about 5 million people have dementia,with Alzheimer’s
disease (AD) accounting for over 3 million.
The goal of the study, developed in the field of nanotechnologies, is to create nanoparticles (NPs)able
to cross the blood-brain barrier to reach the brain, principal site of Alzheimer's disease. Molecules that
can recognize (diagnosis) and destroy (therapy) the amyloid deposits, characteristic of the illness, will be
attached to the nanoparticles, and tested on animal models of the disease (transgenic mice). If the
expectations of the research are attained, future experiments can be performed on humans.
The results can have an enormous impact on the early diagnosis and therapy of a disease of high
incidence, which takes a heavy social cost.
The NAD project involves 19 European research centers of 13 European countries (Italy,France,
Slovakia, Sweden, Netherlands, Hungary, Finland, Greece, Belgium, Spain, United Kingdom, Portugal,
and Denmark)
Research area: NMP-2007-4.0-4 Substantial innovation in the European medical industry:
development of nanotechnology-based systems for in-vivo diagnosis and therapy
(in coordination with topic HEALTH-2007-2.4.1-7 and HEALTH-2007-1.2-3 in Theme 1 "Health")
Prof. Masserini of University of Milano-Bicocca is the scientific coordinator of the project.
|